Citation:Stoffels I, Dissemond J, Poeppel T, Klötgen K, Hillen U, Körber A, et al 2012

From Cancer Guidelines Wiki

Citation


Stoffels I, Dissemond J, Poeppel T, Klötgen K, Hillen U, Körber A, et al. Advantages of preoperative ultrasound in conjunction with lymphoscintigraphy in detecting malignant melanoma metastases in sentinel lymph nodes: a retrospective analysis in 221 patients with malignant melanoma AJCC Stages I and II. J Eur Acad Dermatol Venereol 2012 Jan;26(1):79-85 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21395693.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?Tamsin Parrishcompleted
What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?Lani Teddycompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?